Autoimmune & Chronic Conditions

Pernicious Anemia: An Overview

by

Pernicious anemia is an autoimmune condition that prevents proper use of vitamin B12, and causes neurological damage before anemia appears. This overview explains how the disease affects the body, why diagnosis is frequently missed, and what effective treatment looks like.

What Stops People from Getting Well?

by

People with pernicious anemia often resist treatment even though the long term neurological and health consequences are horrible. This article examines the psychological, cognitive, and systemic barriers that delay care—and how those barriers compound neurological damage over time.

Diagnosis and management of iron deficiency in chronic inflammatory conditions (CIC): is too little iron making your patient sick? – Summary

by

Discover the complexities of identifying and treating iron deficiency in chronic inflammatory conditions, such as chronic kidney disease and heart failure. This article summary explains the article’s practical methods for interpreting ferritin and transferrin saturation levels, alongside guidance on selecting oral or intravenous iron therapies. Derived from the 2020 ASH Education Program.

Associated Conditions: The Bigger Picture (PA)

by

Many PA patients have additional conditions that contribute to ongoing symptoms. Fatigue, brain fog, and weakness often have multiple causes. This guide looks beyond B12 to explain how treating the bigger picture can bring clearer recovery and better outcomes. Why This Matters Pernicious anemia doesn’t occur in isolation. The same autoimmune processes that damage your … Read more

Multiple Autoimmune Mechanisms Beyond Classic Gastritis

by

Pernicious Anemia: Multiple Autoimmune Mechanisms Beyond Classic Gastritis

Breakthrough research reveals why 40–60% of pernicious anemia patients test negative for intrinsic factor antibodies yet still require lifelong B12 therapy. These discoveries identify multiple autoimmune mechanisms affecting B12 absorption and utilization—some involving autoimmune gastritis through non-antibody pathways, others targeting completely different parts of the B12 system. The findings fundamentally expand our understanding of pernicious anemia as a spectrum of autoimmune B12 disorders rather than a single gastric disease.

Recent molecular discoveries have identified anti-CD320 receptor autoantibodies as a major cause of “autoimmune B12 central deficiency,” where patients develop selective nervous system B12 deficiency despite normal serum levels. Combined with genetic studies revealing five risk loci and emerging understanding of T-cell–mediated gastric destruction, these findings reshape the clinical approach to antibody-negative cases. This research demonstrates that pernicious anemia encompasses diverse autoimmune mechanisms affecting multiple points in B12 metabolism, explaining both gastritis-related and non-gastritis forms of the condition.

Read more